Editorial Board — Medscape Rheumatology
Board Members
- Robert I. Fox, MD, PhD
- Scripps Memorial Hospital-Ximed
La Jolla, California
- Scripps Memorial Hospital-Ximed
- Jonathan Kay, MD
- University of Massachusetts Medical School
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts
- University of Massachusetts Medical School
- Muhammad A. Khan, MD, FRCP, MACP
- MetroHealth Medical Center
Cleveland, Ohio
- MetroHealth Medical Center
- Stephen Paget, MD
- Weill Cornell Medical College
Hospital for Special Surgery
New York, New York
- Weill Cornell Medical College
- Sergio Schwartzman, MD
- Weill Cornell Medical College
Hospital for Special Surgery
NewYork-Presbyterian Hospital
New York, New York
- Weill Cornell Medical College
Board Member Details
Robert I. Fox, MD, PhD
Chief, Rheumatology Clinic, Scripps Memorial Hospital/XiMED, La Jolla, California
Robert I. Fox, MD, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Allergan, Inc.; Celgene Corporation; Arena Pharmaceuticals, Inc.; Roche
Received income in an amount equal to or greater than $250 from: Celgene Corporation; Arena Pharmaceuticals, Inc.
Jonathan Kay, MD
Professor of Medicine & Timothy S. and Elaine L. Peterson Chair in Rheumatology, Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School; Physician, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts
Jonathan Kay, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Amgen Inc; AbbVie Inc; Boehringer Ingelheim Pharmaceuticals, Inc. GmbH; Bristol-Myers Squibb; Crescendo Bioscience, Inc; Eli Lilly & Co; Fast Forward Pharmaceuticals, B.V.; Genentech, Inc; GlaxoSmithKline PLC; Janssen Biotech, Inc; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Pfizer, Inc; Samsung Bioepis; Sandoz Inc; Roche Laboratories, Inc.; UCB, Inc
Received research grant from: AbbVie, Inc; Ardea Bioscienses, Inc; Eli Lilly and Company; Pfizer, Inc; Genentech, Inc; Roche Laboratories, Inc.; UCB, Inc
Received an income in an amount equal to or greater than $250 from: Amgen Inc; AbbVie Inc; Boehringer Ingelheim Pharmaceuticals, Inc. GmbH; Bristol-Myers Squibb; Crescendo Bioscience, Inc; Eli Lilly & Co; Fast Forward Pharmaceuticals, B.V.; Genentech, Inc; GlaxoSmithKline PLC; Janssen Biotech, Inc; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Pfizer, Inc; Samsung Bioepis; Sandoz Inc; Roche Laboratories, Inc.; UCB, Inc
Muhammad A. Khan, MD, FRCP, MACP
Professor Emeritus of Medicine, Case Western Reserve University; Staff Physician, Division of Rheumatology, MetroHealth Medical Center, Cleveland, Ohio
Muhammad A. Khan, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: AbbVie Inc.; Novartis Pharmaceuticals Corporation; Eli Lilly and Company
Serve(d) as a speaker or a member of a speakers bureau for: AbbVie Inc.; Novartis Pharmaceuticals Corporation
Received income in an amount equal to or greater than $250 from: AbbVie Inc.; Novartis Pharmaceuticals Corporation
Stephen Paget, MD
Professor of Medicine, Weill Cornell Medical College; Physician-in-Chief Emeritus, Center for Rheumatology, Hospital for Special Surgery, New York, New York
Stephen Paget, MD, has disclosed no relevant financial relationships.
Sergio Schwartzman, MD
Franchellie M. Cadwell Associate Professor of Clinical Medicine, Weill Cornell Medical College; Associate Attending Physician, Hospital for Special Surgery, NewYork-Presbyterian Hospital, New York, New York
Sergio Schwartzman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Genentech BioOncology; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; AbbVie Inc.; Pfizer Inc.; Epirus Biopharmaceuticals; Hospira, Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc.; Crescendo Bioscience, Inc..; Eli Lilly and Company; sanofi-aventis
Served as a board member for: Discus Analytics, LLC; National Psoriasis Foundation
Served on the scientific advisory board for: Crescendo Bioscience, Inc.;
Serve(d) as a speaker or member of a speakers bureau for: Genentech BioOncology; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; AbbVie Inc.; Crescendo Bioscience, Inc.; Pfizer Inc.; Hospira, Inc.; Novratis Pharmaceuticals Corporation; sanofi-aventis; Regeneron Pharmaceuticals, Inc.; UCB Pharma, Inc.
Has stock in: Pfizer Inc.; Medtronic, Inc.; Amgen Inc.; Gilead Sciences, Inc.
